Revision as of 17:35, 16 February 2012 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{chembox}} taken from revid 471983762 of page 2C-D for the Chem/Drugbox validation project (updated: 'CASNo'). |
Latest revision as of 02:26, 28 August 2023 edit Davemck (talk | contribs)Extended confirmed users119,673 editsm renumber duplicate parm |
Line 1: |
Line 1: |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
{{chembox |
|
{{chembox |
|
|
| Verifiedfields = changed |
⚫ |
| verifiedrevid = 413114600 |
|
|
|
| Watchedfields = changed |
⚫ |
| ImageFile1 = 2C-D-Marvin Sketch.png |
|
|
⚫ |
| verifiedrevid = 477216133 |
⚫ |
| ImageSize1 = 180px |
|
|
⚫ |
| ImageFile1 = 2C-D 2DACS.svg |
|
⚫ |
| ImageSize1 = 150px |
|
| ImageFileL2 = 2C-D-3d-sticks.png |
|
| ImageFileL2 = 2C-D-3d-sticks.png |
|
| ImageSizeL2 = 100px |
|
|
| ImageFileR2 = 2C-D_animation.gif |
|
| ImageFileR2 = 2C-D_animation.gif |
|
⚫ |
| PIN = 2-(2,5-Dimethoxy-4-methylphenyl)ethan-1-amine |
|
| ImageSizeR2 = 125px |
|
|
⚫ |
| OtherNames = {{bulletedlist|2,5-Dimethoxy-4-methyl-phenethylamine| 4-Methyl-2,5-dimethoxyphenethylamine| LE-25}} |
⚫ |
| IUPACName = 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminoethane |
|
|
⚫ |
|Section1={{Chembox Identifiers |
⚫ |
| OtherNames = 2,5-Dimethoxy-4-methyl-phenethylamine |
|
⚫ |
| Section1 = {{Chembox Identifiers |
|
|
| InChI = 1/C11H17NO2/c1-8-6-11(14-3)9(4-5-12)7-10(8)13-2/h6-7H,4-5,12H2,1-3H3 |
|
| InChI = 1/C11H17NO2/c1-8-6-11(14-3)9(4-5-12)7-10(8)13-2/h6-7H,4-5,12H2,1-3H3 |
|
| InChIKey = UNQQFDCVEMVQHM-UHFFFAOYAJ |
|
| InChIKey = UNQQFDCVEMVQHM-UHFFFAOYAJ |
Line 19: |
Line 18: |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey = UNQQFDCVEMVQHM-UHFFFAOYSA-N |
|
| StdInChIKey = UNQQFDCVEMVQHM-UHFFFAOYSA-N |
|
|
| CASNo_Ref = {{cascite|correct|CAS}} |
|
| CASNo = <!-- blanked - oldvalue: 24333-19-5 --> |
|
| CASNo = 24333-19-5 |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
| UNII = 7J43GY6ONS |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 119559 |
|
| ChemSpiderID = 119559 |
Line 25: |
Line 27: |
|
| SMILES = O(c1cc(c(OC)cc1CCN)C)C |
|
| SMILES = O(c1cc(c(OC)cc1CCN)C)C |
|
}} |
|
}} |
|
| Section2 = {{Chembox Properties |
|
|Section2={{Chembox Properties |
|
| Formula = C<sub>11</sub>H<sub>17</sub>NO<sub>2</sub> |
|
| Formula = |
|
|
| C=11 | H=17 | N=1 | O=2 |
|
| MolarMass = 195.26 g/mol |
|
|
| Appearance = |
|
| Appearance = |
|
| Density = |
|
| Density = |
|
| MeltingPt = 213-214 °C (]) |
|
| MeltingPtC = 213 to 214 |
|
|
| MeltingPt_notes = (]) |
|
| BoilingPt = |
|
| BoilingPt = |
|
| Solubility = }} |
|
| Solubility = }} |
|
| Section3 = {{Chembox Hazards |
|
|Section3={{Chembox Hazards |
|
| MainHazards = |
|
| MainHazards = |
|
| FlashPt = |
|
| FlashPt = |
|
| Autoignition = }} |
|
| AutoignitionPt = |
|
|
}} |
|
|
| Section4 = {{Chembox Pharmacology |
|
|
| Legal_status = |
|
|
| Legal_AU = |
|
|
| Legal_BR = F2 |
|
|
| Legal_CA = Schedule III |
|
|
| Legal_DE = Anlage I |
|
|
| Legal_US = Schedule I |
|
|
}} |
|
}} |
|
}} |
|
|
|
|
|
'''2C-D''' ('''2,5-dimethoxy-4-methylphenethylamine''' or '''2C-M''') is a ] of the ] that is sometimes used as an ]. It was first synthesized in 1970 by a team from the Texas Research Institute of Mental Sciences,<ref name="pmid5412084">{{cite journal |vauthors=Ho BT, Tansey LW, Balster RL, An R, McIsaac WM, Harris RT |title=Amphetamine analogs. II. Methylated phenethylamines |journal=Journal of Medicinal Chemistry |volume=13 |issue=1 |pages=134–5 |date=January 1970 |pmid=5412084 |doi= 10.1021/jm00295a034}}</ref> and its activity was subsequently investigated in humans by ]. In his book '']'', Shulgin lists the dosage range as being from 20 to 60 mg.<ref name=Shulgin></ref> Lower doses of 10 mg or less have been explored for ].<ref>{{Cite web|last=Nez|first=Hosteen|date=2015|title=Erowid 2C-D Vault : Smart Pills|url=https://www.erowid.org/chemicals/2cd/2cd_smartpills1.shtml|url-status=live|access-date=2022-01-09|website=www.erowid.org|archive-url = https://web.archive.org/web/20010709231503/http://www.erowid.org/chemicals/2cd/2cd_smartpills1.shtml |archive-date = 2001-07-09 }}</ref> |
|
|
|
|
|
Not much information is known about the toxicity of 2C-D, as no major studies have been conducted. According to Shulgin, the effects of 2C-D typically last for 4–6 hours.<ref name=Shulgin/> Shulgin himself referred to this substance as a “pharmacological ],” meaning that when mixed with other substances, it can extend or potentiate their effects without coloring the experience too much, in a manner similar to how tofu absorbs the flavors of sauces or spices it is cooked with. ], working in Germany, explored the use of 2C-D under the name LE-25 in psychotherapeutic research.{{citation needed|date=November 2018}} |
|
|
|
|
|
==Drug prohibition laws== |
|
|
|
|
|
===China=== |
|
|
As of October 2015 2C-D is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=zh | access-date=1 October 2015 | archive-url=https://web.archive.org/web/20151001222554/http://www.sfda.gov.cn/WS01/CL0056/130753.html | archive-date=1 October 2015 | url-status=dead }}</ref> |
|
|
|
|
|
===Canada=== |
|
|
As of October 31, 2016; 2C-D is a controlled substance (Schedule III) in Canada.<ref>{{Cite web|url=http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php|title=Canada Gazette – Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)|date=4 May 2016}}</ref> |
|
|
|
|
|
===Denmark=== |
|
|
2C-D is added to the list of Schedule B controlled substances.<ref>{{cite web |url=https://www.retsinformation.dk/Forms/R0710.aspx?id=137169 |title = Retsinformation}}</ref> |
|
|
|
|
|
===Finland=== |
|
|
Listed in the government decree on psychoactive substances banned from the consumer market.<ref>{{cite web | url=https://www.finlex.fi/fi/laki/ajantasa/2014/20141130 | title=FINLEX ® - Ajantasainen lainsäädäntö: Valtioneuvoston asetus kuluttajamarkkinoilta… 1130/2014 }}</ref><ref>{{cite web | url=https://www.finlex.fi/fi/laki/alkup/2021/20210733 | title=FINLEX ® - Säädökset alkuperäisinä: Valtioneuvoston asetus kuluttajamarkkinoilta… 733/2021 }}</ref> |
|
|
|
|
|
===Germany=== |
|
|
2C-D is an ] controlled drug. |
|
|
|
|
|
===Sweden=== |
|
|
] health ministry {{ill|Statens folkhälsoinstitut|sv|Statens folkhälsoinstitut}} classified 2C-D as "health hazard" under the act {{ill|Lagen om förbud mot vissa hälsofarliga varor|sv|Lagen om förbud mot vissa hälsofarliga varor}} (Act on the Prohibition of Certain Goods Dangerous to Health) as of Mar 1, 2005, in their regulation SFS 2005:26 listed as "2,5-dimetoxi-4-metylfenetylamin (2C-D)", making it illegal to sell or possess.<ref>{{cite web |last=Johansson |first=Morgan |url=http://www.notisum.se/rnp/sls/sfs/20050026.pdf |title=Svensk författningssamling |access-date=January 24, 2022 |archive-date=September 29, 2013 |archive-url=https://web.archive.org/web/20130929063138/http://www.notisum.se/rnp/sls/sfs/20050026.pdf |url-status=dead }}</ref> |
|
|
|
|
|
===United States=== |
|
|
2C-D became a ] in the United States as of July 9, 2012, with the signing of Food and Drug Administration Safety and Innovation Act.<ref>{{Cite web |url=http://thomas.loc.gov/cgi-bin/query/z?c112:S.3187: |title=S. 3187 |access-date=2012-07-11 |archive-date=2012-12-14 |archive-url=https://web.archive.org/web/20121214091910/http://thomas.loc.gov/cgi-bin/query/z?c112:S.3187: |url-status=dead }}</ref> On a state level, both ] and ] list 2C-D under schedule I. |
|
|
|
|
|
==References== |
|
|
{{reflist}} |
|
|
|
|
|
{{2Cs}} |
|
|
{{Hallucinogens}} |
|
|
{{Phenethylamines}} |
|
|
|
|
|
] |
|
|
] |
|
|
] |